Heaves hit for Stirling
Tuesday, 29 July, 2008
Stirling Products [ASX: STI] has been granted an Australian patent or the treatment of heaves in horses with R-salbutamol.
The company has already been granted a patent for the same concept from South Africa, and Stirling representatives say they expect more grants to follow shortly.
A patent application for the inhaler device developed to help administer the drug, the Equinehaler, has also been lodged.
Heaves, also known as recurrent airway obstruction, affects an estimated 25-30 per cent of all horses in Europe and the US.
Stirling is also looking at using R-salbutamol - a highly purified version of salbutamol, better known as Ventolin - as a growth agent and as a treatment of obesity in dogs.
Does exercise really extend lifespan? It's complicated
Physical activity is seen as a way to extend the human lifespan, but the benefits of physical...
Nature helps to relieve physical pain
Experiencing nature, even in the form of watching nature videos, can alleviate acute physical pain.
SEQ koala population carries immunity to retrovirus
Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...